lobbying_activities: 2503981

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2503981	12c11c87-aa4b-4691-95fb-80172ab11942	Q3	WATKINS & EAGER PLLC	401104403	ZYNERBA PHARMACEUTICALS, INC.	2020	third_quarter	HCR	Assist in the development & approval process before the FDA of Zynerba's lead therapeutic for the potential treatment of behavioral symptoms associated with Fragile X Syndrome.	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE			0	0	2020-10-05T13:28:00.437000-04:00